The Psychiatric Institute, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL 60612, USA.
Neuropharmacology. 2011 Jun;60(7-8):1058-63. doi: 10.1016/j.neuropharm.2010.09.006. Epub 2010 Sep 22.
In wild-type (WT) mice, the antibiotic minocycline inhibits development of cocaine-induced locomotor sensitization. Some of the actions of minocycline may involve the 5-lipoxygenase (5-LOX) pathway. We used the model of 5-LOX-deficient mice to investigate whether 5-LOX participates in minocycline's influence on the effects of cocaine. Locomotor sensitization was induced by 4 daily cocaine injections and the phosphorylation status of GluR1 glutamate receptors was assayed in brain samples. Minocycline failed to affect cocaine sensitization in 5-LOX-deficient mice. In these mice, neither cocaine nor minocycline 4-day treatment altered GluR1 phosphorylation. In WT mice in which minocycline inhibited development of cocaine sensitization, a 4-day cocaine treatment increased GluR1 phosphorylation at both Ser831 and Ser845 sites in the frontal cortex but not the striatum; further, this effect was prevented by minocycline. Under basal conditions and in response to a single cocaine injection the levels of GluR1, GluR2, and GluR3 AMPA receptor subunits did not differ between WT and 5-LOX-deficient mice, but the response of GluR1 phosphorylation to a single cocaine injection was greater under the 5-LOX deficiency. Hence, in WT mice GluR1 phosphorylation increased only in the frontal cortex and only at the Ser831 site. In 5-LOX-deficient mice, acute cocaine injection increased both Ser831 and Ser845 phosphorylation both in the frontal cortex and in the striatum. We suggest that in studying minocycline's action on cocaine's effects and/or addiction in humans, it would be important to consider the characterization of the subjects' 5-LOX system. This article is part of a Special Issue entitled 'Trends in neuropharmacology: in memory of Erminio Costa'.
在野生型(WT)小鼠中,抗生素米诺环素抑制可卡因诱导的运动敏化的发展。米诺环素的一些作用可能涉及 5-脂氧合酶(5-LOX)途径。我们使用 5-LOX 缺陷型小鼠模型来研究 5-LOX 是否参与米诺环素对可卡因作用的影响。通过 4 天可卡因注射诱导运动敏化,并在脑样本中测定 GluR1 谷氨酸受体的磷酸化状态。米诺环素未能影响 5-LOX 缺陷型小鼠的可卡因敏化。在这些小鼠中,可卡因或米诺环素 4 天治疗均未改变 GluR1 磷酸化。在 WT 小鼠中,米诺环素抑制可卡因敏化的发展,4 天可卡因处理增加了额皮质中 GluR1 的 Ser831 和 Ser845 位点的磷酸化,但纹状体中没有;此外,米诺环素阻止了这种作用。在基础条件下和对单次可卡因注射的反应中,WT 和 5-LOX 缺陷型小鼠之间的 GluR1、GluR2 和 GluR3 AMPA 受体亚基的水平没有差异,但 GluR1 磷酸化对单次可卡因注射的反应在 5-LOX 缺陷型小鼠中更大。因此,在 WT 小鼠中,GluR1 磷酸化仅在前额皮质中增加,并且仅在 Ser831 位点增加。在 5-LOX 缺陷型小鼠中,急性可卡因注射增加了额皮质和纹状体中 Ser831 和 Ser845 磷酸化。我们认为,在研究米诺环素对可卡因作用和/或人类成瘾的作用时,考虑研究对象的 5-LOX 系统特征将非常重要。本文是题为“神经药理学趋势:纪念 Erminio Costa”的特刊的一部分。